5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole
- CAS No.97963-62-7
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High purity 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole serves as a critical intermediate for Pantoprazole synthesis, ensuring reliable API production.
Request Bulk PricingProduct Technical Details
Product Overview
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole is a specialized pharmaceutical intermediate characterized by its high chemical stability and precise molecular structure. This compound plays an indispensable role in the multi-step synthesis of Proton Pump Inhibitors (PPIs), specifically serving as a key building block for Pantoprazole production. Our manufacturing process adheres to strict quality management systems, ensuring consistent batch-to-batch reliability for global pharmaceutical partners.
As a leading supplier in the fine chemicals sector, we understand the critical nature of intermediate purity in downstream API synthesis. Our facility employs advanced crystallization and purification technologies to achieve exceptional assay levels, minimizing impurities that could affect subsequent reaction yields. This product is designed for industrial-scale pharmaceutical manufacturing, supporting efficient process chemistry and regulatory compliance.
Technical Specifications
Quality control is paramount in pharmaceutical intermediate supply. Each batch undergoes rigorous analytical testing including HPLC, melting point determination, and loss on drying analysis. The following table outlines the typical specification profile based on our factory standards and recent production data:
| Items of Analysis | Standard of Analysis | Test Results |
|---|---|---|
| Appearance | Light beige powder | Light beige powder |
| Loss on drying | ≤1.0% | 0.43% |
| Decomposition point | ≥252℃ | 252.3℃ |
| Ethanol dissolution test | No impurities or insolubles | Conform |
| Purity (HPLC) | ≥99.0% | 99.91% |
| Conclusion | Conforms to Factory Standard | |
Industrial Applications
The primary application of this benzimidazole derivative is in the synthesis of Pantoprazole, a widely used medication for treating gastroesophageal reflux disease. The difluoromethoxy group and mercapto functionality provide the necessary reactivity for coupling reactions during API construction. Pharmaceutical manufacturers rely on this intermediate for its consistent performance in nucleophilic substitution and cyclization steps.
- Essential precursor for Proton Pump Inhibitor API synthesis
- Optimized for large-scale industrial chemical processes
- Compatible with standard pharmaceutical manufacturing workflows
- Supports regulatory documentation and audit requirements
Storage and Handling
To maintain product integrity, 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole should be stored in a cool, ventilated environment away from direct sunlight and moisture. Standard industrial packaging includes 25 kg drums, with customization available based on logistical requirements. Proper handling procedures ensure safety and prevent degradation during transport and warehouse storage. We provide comprehensive Certificates of Analysis (COA) with every shipment to verify compliance with specified parameters.
